Let’s Get to Work.
At Huron, we believe there’s a better way to achieve the type of change that delivers long-term success for our clients. It takes genuine collaboration, deep expertise, and steady focus. It takes true partnership, from day one.
Sustainable, enduring change doesn’t just happen. It requires a dedicated partner to produce measurable, long-lasting results – results that improve performance today, help chart the course for tomorrow and prepare our clients for the challenges of the future.
It’s this passionate commitment to our clients’ success that drives us. We are Huron. Let’s get to work.
SUBSCRIBE TO HURON INSIGHTS
Sign up to get all of the great Huron insights.
Newsletter Subscriptions-
Huron Acquires ADI Strategies
The transaction creates one of the largest and fastest growing Oracle application and analytics practices.
-
Bonus Slide
Extra information here
-
Bonus Slide 2
Extra information here 2
-
Healthcare
Strategy, clinical, finance, operations, technology & coaching
-
Business Advisory
Advisory, operations, turnaround & valuation
-
Life Sciences
Strategy, compliance & operations
-
Enterprise Solutions
ERP, EPM, CRM, & business analytics
-
Higher Education
Strategy, operations, technology & research
-
Technology
Software, partner & proprietary tools
-
Technology
Our software, partner platforms and proprietary tools are built to drive performance, enablement and support. Whether through operational improvements, compliance facilitation or actionable insights, our technology-supported solutions seamlessly fit into our clients’ structures.
-
Life Sciences
The stakes have never been higher for leaders in the life sciences industry. Improving patient outcomes and delivering real innovation and value are held paramount, but actually making that happen can seem almost insurmountable in today’s dynamic industry. Scientific pressures and stricter government guidelines are making it increasingly challenging for life sciences companies to go to market. Patients’ treatment decisions are shifting further into the payer’s hands. And with the government as one of the largest payers, companies are finding themselves under stricter regulations. Additionally, R&D models are now evaluated both from a cost-to-innovate perspective as well as a market perspective, forcing life sciences companies to determine the ultimate value their products will bring to a given patient population well in advance of approval and commercialization.
-
Healthcare
Transformation is underway across all aspects of the healthcare industry — from demands for greater transparency around the quality and cost of care, to rising consumer influence and increasing pressures to manage regulatory volatility. There is also the pressing need to engage and empower physicians and other healthcare professionals while simultaneously finding ways to work with an increasing number of new partners, build population health models, embrace new payment structures and leverage technology.